|
| Status |
Public on Jul 23, 2024 |
| Title |
Engineered T cell therapy for central nervous system injury |
| Organisms |
Homo sapiens; Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
Other
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
39232158 |
| |
| Submission date |
Oct 23, 2022 |
| Last update date |
Oct 22, 2024 |
| Contact name |
Jonathan Kipnis |
| Organization name |
Washington University in Saint Louis
|
| Department |
Pathology and Immunology
|
| Lab |
Kipnis Lab
|
| Street address |
4515 McKinley Ave
|
| City |
Saint Louis |
| State/province |
MO |
| ZIP/Postal code |
63110 |
| Country |
USA |
| |
|
| Platforms (3) |
| GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
| GPL19057 |
Illumina NextSeq 500 (Mus musculus) |
| GPL24247 |
Illumina NovaSeq 6000 (Mus musculus) |
|
| Samples (230)
|
|
| This SuperSeries is composed of the following SubSeries:
|
| GSE189812 |
Engineered T cell therapy for central nervous system injury [control tissues TCR scRNA-seq] |
| GSE216388 |
Engineered T cell therapy for central nervous system injury [FACS-Tcells] |
| GSE216389 |
Engineered T cell therapy for central nervous system injury [CD45+ scRNA-seq] |
| GSE216390 |
Engineered T cell therapy for central nervous system injury [spinal cord TCR scRNA-seq] |
| GSE273504 |
Engineered T cell therapy for central nervous system injury [CSF RNAseq + VDJ] |
|
| Relations |
| BioProject |
PRJNA893390 |
Less...
More...